HUMANE MILCH OLIGOSACCHARIDE:
Hegar B et al. Pediatr Gastroenterol Hepatol Nutr 2019;22(4):330-340. The Role of Two Human Milk Oligosaccharides, 2'-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition.
Kunz C et al. JPGN 2017;64(5): p. 789-798. Influence of Gestational Age, Secretor, and Lewis Blood Group Status on the Oligosaccharide Content of Human Milk.
Bode L. Glycobiology 2012;22(9):1147–1162. Human milk oligosaccharides: every baby needs a sugar mama.
Zivkovic AM et al. Proc Natl Acad Sci USA 2011;108(suppl 1):4653-4658. Human milk glycobiome and its impact on the infant gastrointestinal microbiota.
Xiao L et al. Eur J Immunol 2019;49(7):1001-1014. Human milk oligosaccharides promote immune tolerance via direct interactions with human dendritic cells.
Donovan SM and Comstock SS. Ann Nutr Metab 2016;69 (suppl 2):42-51.Human Milk Oligosaccharides Influence Neonatal Mucosal and Systemic Immunity.
Ayechu-Muruzabal V et al. Front Pediatr 2018;6:239. Diversity of Human Milk Oligosaccharides and Effects on Early Life Immune Development.
G et al. J Pediatr Gastroenterol Nutr 2017;64(4):624-631. Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial.
Vandenplas Y et al. Nutrients 2018;10(9):E1161. Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula.
Nowak-Wegrzyn A et al. Nutrients 2019;11(7):E1447. Confirmed Hypoallergenicity of a Novel Whey-Based Extensively Hydrolyzed Infant Formula Containing Two Human Milk Oligosaccharides.
Niggemann B et al. Pediatr Allergy Immunol 2008; 19(4): 348-354. Safety and efficacy of a new extensively hydrolyzed formula for infants with cow's milk protein allergy.
Haschke F et al. Nestle Nutr Inst Workshop Ser 2019;90:107-120. Early-Life Nutrition, Growth Trajectories, and Long-Term Outcome.
Carlson SE and Colombo J. Adv Pediatr. 2016;63:453–71. Docosahexaenoic Acid and Arachidonic Acid Nutrition in Early Development.
Kennedy K et al. Am J Clin Nutr 1999;70(5):920-927. Double-blind, randomized trial of a synthetic triacylglycerol in formula-fed term infants: effects on stool biochemistry, stool characteristics, and bone mineralization.
Francavilla R et al. Pediatr Allergy Immunol 2012;23(5):420-427. Effect of lactose on gut microbiota and metabolome of infants with cow's milk allergy.
Azad MB et al. Clin Exp Allergy 2015;45(3):632-643. Infant gut microbiota and food sensitization: associations in the first year of life.
Thompson-Chagoyan OC et al. Int Arch Allergy Immunol 2011;156(3):325–332. Faecal microbiota and short-chain fatty acid levels in faeces from infants with cow's milk protein allergy.
West CE et al. Clin Exp Allergy 2015;45(1):43–53. The gut microbiota and its role in the development of allergic disease: a wider perspective.
Jalonen T. J allergy Clin Immunol 1991;88(5):737-742. Identical intestinal permeability changes in children with different clinical manifestations of cow's milk allergy.
Critt enden RG and Bennett LE. J Am Coll Nutr 2005;24(6suppl):582S–591S. Cow's milk allergy: a complex disorder.
Chin AM et al. Semin Cell Dev Biol 2017;66:81-93. Morphogenesis and maturation of the embryonic and postnatal intestine.
Tanaka M and Nakayama J. Allergol Int 2017;66(4):515-522. Development of the gut microbiota in infancy and its impact on health in later life.
Woicka-Kolejwa K et al. Postepy Dermatol Alergol 2016;33(2):109-113. Food allergy is associated with recurrent respiratory tract infections during childhood.
Juntti H et al. Acta Otolaryngol 1999;119(8):867-873. Cow's milk allergy is associated with recurrent otitis media during childhood.
Tikkanen S et al. Acta Paediatr 2000; 89(10):1174-1180. Status of children with cow's milk allergy in infancy by 10 years of age.
Azad MB et al. J Nutr, 2018; 148(11): p. 1733-1742. Human Milk Oligosaccharide Concentrations Are Associated with Multiple Fixed and Modifiable Maternal Characteristics, Environmental Factors, and Feeding Practices.
Jantscher-Krenn E and Bode L. Minerva Pediatr. 2012; 64:83-99. Human milk oligosaccharides and their potential benefits for the breast-fed neonate.
STUDIEN THICKENUP® CLEAR:
ThickenUP® clear - Studien-Übersicht: Die folgende Literaturübersicht gibt einen Überblick zu den verschiedenen Studien, die im Zeitverlauf von der Markteinführung bis 2023 mit dem Andickungspulver ThickenUP® clear durchgeführt wurden.
Herunterladen
ThickenUP® clear - Compendium of Scientific Literature: Diese Zusammenfassung gibt in Form eines interaktiven, klickbaren PDFs einen Einblick in 18 Studien mit dem Andickungspulver ThickenUP® clear und umfasst deren Ziele, Methodiken, Ergebnisse und Schlussfolgerungen – von realen Evidenzstudien, Interventionsstudien über pro- und retrospektive Studien bis hin zu open-label und rheologischen Studien an Patient:innen mit oropharyngealer Dysphagie.
Herunterladen
STUDIEN DYSPHAGIE:
Galán Sánchez-Heredero MJ, et al. [Relationship between dysphagia and malnutrition in patients over 65 years of age]. Enferm Clin. 2014;24(3):183-90.
Belafsky PC, Mouadeb DA, Rees CJ, Pryor JC, Postma GN, Allen J, Leonard RJ. Validity and Reliability of the Eating Assessment Tool (EAT-10). Annals of Otology Thinology & Laryngology 2008; 117 (12): 919-924.
American Gastroenterological Association (AGA). AGA technical review on management of oropharyngeal dysphagia. Gastroenterology. 1999; 116:455-478.
Leonard R, et al. Effects of Bolus Rheology on Aspiration in Patients with Dysphagia. Journal of the Academy of Nutrition and Dietetics. 2014; 114(4): 590-594
Rofes L et al.The effects of a xanthan gum-based thickener on the swallowing function of patients with dysphagia. Aliment Pharmacol Ther. 2014 May;39(10):1169-79.
PUBLIKATIONEN DYSPHAGIE:
Pureed foods for people with dysphagia. Clinical Nutrition Highlights 2023, Volume 13, Issue 1.
Herunterladen
Hydration management in patients with dysphagia. Clinical Nutrition Highlights 2021, Volume 8, Issue 3.
Herunterladen
How and why thickened liquids improve swallowing safety and efficiency. Clinical Nutrition Highlights 2021, Volume 11, Issue 1.
Herunterladen
SCREENING DYSPHAGIE (EAT-10):
Schindler, A., De Fátima Lago Alvite, M., Robles-Rodriguez, W. G., Barcons, N. & Clavé, P. (2023). History and Science behind the Eating Assessment Tool-10 (Eat-10): Lessons Learned. 2023. The Journal Of Nutrition Health & Aging, 27(8), 597–606.
In PubMed öffnen
Giudici, K. V. (2023). Challenges for Assessing Oropharyngeal Dysphagia: The Role of the Eating Assessment Tool-10 (EAT-10). The Journal Of Nutrition Health & Aging, 27(8), 595–596.
Fedecostante, M., Dell’Aquila, G. & Cherubini, A. (2023). Screening for Dysphagia: Time Is Now. The Journal Of Nutrition Health & Aging, 27(8), 593–594.
ICU-RANGE:
McClave SA et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). J Parenter Enteral Nutr 2016;40(2):159-211.
Rushdi T.A. et al Control of diarrhea by fiber-enriched diet in ICU on enteral nutrition: a prospective randomized controlled trial. Clin Nutr 2004; 24:1344-1352
Spapen H et al, Soluble fibre reduces the incidence of diarrhea in septic patients receiving total enteral nutrition: a prospective double-blind, randomized and controlled trial. Clin Nutr 2001;20:301-305.
PEPTAMEN:
Verdauung und Resorption bei Patienten mit chronischer Diarrhoe:
Alexander DD, et al. Nutritional and health benefits of semi-elemental diets: A comprehensive summary of the literature. World J Gastrointest Pharmacol Ther 2016;7(2):306-319
Jahan-Mihan A, et al. Dietary proteins as determinants of metabolic and physiologic functions of the gastrointestinal tract. Nutrients 2011;3(5): doi:10.3390/nu3050574
Lloyd DA, Powell-Tuck J. Artificial nutrition: Principles and practice of enteral feeding. Clin Colon Rectal Surg 2004;17(2):107-118
Bach AC, Babayan VK. Medium-chain triglycerides: An update. Am J Clin Nutr 1982;36:950-962
Borlase BC, et al. Tolerance to enteral tube feeding diets in hypoalbuminemic critically ill, geriatric patients. Surg Gyn Obstet 1992;174:181-188
Tiengou LE, et al. Semi-elemental formula or polymeric formula: is there a better choice for enteral nutrition in acute pancreatitis? Random comparative study. J Parent Ent Nutr 2006;30(2):1-5
Hauner H, Kocsis A, Jaeckel B, Martignoni M, Hauner D, Holzapfel C. Häufigkeit eines Risikos für Mangelernährung bei Patienten in onkologischen Schwerpunktpraxen – eine Querschnittserhebung [Prevalence of malnutrition risk in patients of cancer outpatient clinics - a cross-sectional survey]. Dtsch Med Wochenschr. 2020 Jan;145(1):e1-e9. German.
Devries MC, Phillips SM. Supplemental protein in support of muscle mass and health: advantage whey. J Food Sci. 2015 Mar;80 Suppl 1:A8-A15.
Phillips SM. Current Concepts and Unresolved Questions in Dietary Protein Requirements and Supplements in Adults. Front Nutr. 2017 May 8;4:13.
Kaegi-Braun N, Mueller M, Schuetz P, Mueller B, Kutz A. Evaluation of Nutritional Support and In-Hospital Mortality in Patients With Malnutrition. JAMA Netw Open. 2021;4(1):e2033433.
KLINISCHE STUDIEN:
NEU!
Szczubełek, M. et al., Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients, Nutrients 2021; 13, 4112.NEU!
Yanai H. et al., The Crohn’s disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn’s disease (CDED-AD): an open-label, pilot, randomized Trial, Lancet Gastroenterol Hepatol 2022; 7: 49–59.Levine et al., A Case-Based Approach to New Directions in Dietary Therapy of Crohn’s Disease: Food for Thought, Nutrients 2020, 12; 880.
Levine et al., Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial Gastroenterology, 2019;157:440-450.
Levine A & Wine E., Effects of enteral nutrition on Crohn’s disease: clues to the impact of diet on disease pathogenesis, Inflamm Bowel Dis. 2013;19:1322-1329.
Sigall-Boneh et al., Dietary Therapies Induce Rapid Response and Remission in Pediatric Patients With Active Crohn’s Disease, Clin Gastroenterol Hepatol 2020 Apr 14;S1542-3565(20)30487-0. ahead of print.
Sigall-Boneh et al., Dietary Therapy With the Crohn’s Disease Exclusion Diet is a Successful Strategy for Induction of Remission in Children and Adults Failing Biological Therapy, J Crohns Colitis. 2017;11(10):1205-1212.
Sigall-Boneh et al., Partial enteral nutrition with a Crohn’s disease exclusion diet is effective for induction of remission in children and young adults with Crohn’s disease, Inflamm Bowel Dis 2014;20:1353-1360.
ÜBERSICHTSARBEITEN:
Levine et al., Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases, Gut 2018;67:1726–1738.Levine et al., Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases, Clin Gastroenterol Hepatol 2020;18:1381–1392.
Moriczi et al., Predictors of Response to Exclusive Enteral Nutrition in Newly Diagnosed Crohn´s Disease in Children: PRESENCE Study from SEGHNP . Nutrients 2020, 12; 1012.
Herrador-López M., Martín-Masot R. & Navas-López V., EEN Yesterday and Today… CDED Today and Tomorrow, Nutrients 2020, 12(12), 3793.
52-WOCHEN PROGRAMM:
Bischoff S C et al. Int J Obes (Lond). 2012 Apr;36(4):614-24.. Multicenter evaluation of an interdisciplinary 52-week weight loss program for obesity with regard to body weight, comorbidities and quality of life—a prospective study.
Janmy D A et al. Obesity (Silver Spring). 2019 Jan;27(1):22-29. Effectiveness of a Total Meal Replacement Program (OPTIFAST Program) on Weight Loss: Results from the OPTIWIN Study.
Reider, S.J.; Moosmang, S.; Tragust, J.; Trgovec-Greif, L.; Tragust, S.; Perschy, L.; Przysiecki, N.; Sturm, S.; Tilg, H.; Stuppner, H.; Rattei, T.; Moschen, A.R.: Prebiotic Effects of Partially Hydrolyzed Guar Gum on the Composition and Function of the Human Microbiota—Results from the PAGODA Trial. Nutrients 2020, 12, 1257.
VERSTOPFUNG:
Takahashi H. et al: Influence of Partially Hydrolysed Guar Gum on Constipation in Women. J Nutr Socio Vitaminol, 1994; 40: 251-259.
Polymeros D. et al: Partially Hydrolyzed Guar Gum Accelerates Colonic Transit Time and Improves Symptoms in Adults with Chronic Constipation. Dig Dis Sci., 2014; 59(9): 2207-2214.
Takahashi H. et al: Effect of Partially Hydrolyzed Guar Gum on Fecal Output in Human Volunteers. Nutrition Research, 1993; 13(6): 649-657.
Patrick P. et al: Effect of Supplements of PHGG on the Occurrence of Constipation and Use of Lacative Agents. JADA, 1998; 98(8): 912-914.
DURCHFALL:
Alam N. et al: Partially Hydrolyzed Guar Gum Supplemented Comminuted Chicken Diet in Persistent Diarrhea: A Randomized Controlled Trial. Arch Dis Child, 2005; 90: 195-199.
Nakao M. et al: Usefulness of Soluble Dietary Fiber for the Treatment of Diarrhea During Enteral Nutrition in Elderly Patients, Nutrition, 2002; 18: 35–39.
Homann H.-H. et al: Reduction in Diarrhea Incidence by Soluble Fiber in Patients Receiving Total or Supplemental Enteral Nutrition. Journal of Parenteral and Enteral Nutrition, 1994; 18(6): 486-490.
Bowling T.E. et al: Reversal by Short-Chain Fatty Acids of Colonic Fluid Secretion Induced by Enteral Feeding. Lancet, 1993; 342(8882): 1266–1268.
Homann H.-H. et al: The Beneficial Effects of PHGG In Enteral Nutrition in Medical And Surgical Patients. Clinical Nutrition, 2004; 1: 59-62.
REIZDARM:
Parisi G. et al: High-Fiber Diet Supplementation in Patients with Irritable Bowel Syndrome (IBS). Digestive Diseases and Sciences, 2002; 47(8): 1697-1704.
Giaccari S. et al: Partially Hydrolyzed Guar Gum: A Fiber as Coadjuvant in the Irritable Colon Syndrome. Clin Ter, 2001; 152(1): 21-25.
Parisi G. et al: Treatment Effects of Partially Hydrolyzed Guar Gum on Symptoms and Quality of Life of Patients with Irritable Bowel Syndrome. Digestive Diseases and Sciences, 2005; 50(6): 1107–1112.
In PubMed öffnenL. RHAMNOSUS GG:
do Carmo MS , Santos CID , Araújo MC , Girón JA , Fernandes ES , Monteiro-Neto V . Probiotics, mechanisms of action, and clinical perspectives for diarrhea management in children. Food Funct. 2018 Oct 17;9(10):5074-5095.
Bowling TE, Raimundo AH, Grimble GK, Silk DB. Reversal by short-chain fatty acids of colonic fluid secretion induced by enteral feeding. Lancet. 1993 Nov 20;342(8882):1266-8.
Canani RB, Cirillo P, Terrin G, Cesarano L, Spagnuolo MI, De Vincenzo A, Albano F, Passariello A, De Marco G, Manguso F, Guarino A. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ. 2007 Aug 18;335(7615):340.
Pant AR, Graham SM, Allen SJ, Harikul S, Sabchareon A, Cuevas L, Hart CA. Lactobacillus GG and acute diarrhoea in young children in the tropics. J Trop Pediatr. 1996 Jun;42(3):162-5.
Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999 Nov;135(5):564-8.
Fox MJ, Ahuja KD, Robertson IK, Ball MJ, Eri RD. Can probiotic yogurt prevent diarrhoea in children on antibiotics? A double-blind, randomised, placebo-controlled study. BMJ Open. 2015 Jan 14;5(1):e006474.
Guarino A, Canani RB, Spagnuolo MI, Albano F, Di Benedetto L. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr. 1997 Nov;25(5):516-9.
PHGG:
Velázquez M, Davies C, Marett R, Slavin J. L, Feirtag J. M. Effect of Oligosaccharides and Fibre Substitutes on Short-chain Fatty Acid Production by Human Faecal Microflora. Anaerobe. 2000 6(2):87–92.
Carlson J, Gould T, Slavin J. In vitro analysis of partially hydrolyzed guar gum fermentation on identified gut microbiota. Anaerobe. 2016 Dec;42:60-66.
Okubo T, Ishihara N, Takahashi H, Fujisawa T, Kim M, Yamamoto T, Mitsuoka T. Effects of Partially Hydrolyzed Guar Gum Intake on Human Intestinal Microflora and Its Metabolism. Bioscience, Biotechnology, and Biochemistry, 1994;58 (8), 1364–1369.
Ohashi Y, Sumitani K, Tokunaga M, Ishihara N, Okubo T, Fujisawa T. Consumption of partially hydrolysed guar gum stimulates Bifidobacteria and butyrate-producing bacteria in the human large intestine. Benef Microbes. 2015;6(4):451-5.
Takahashi H, Wako N, Okubo T, Ishihara N, Yamanaka J, Yamamoto T. Influence of partially hydrolyzed guar gum on constipation in women. J Nutr Sci Vitaminol (Tokyo). 1994 Jun;40(3):251-9.
Witte MB, Barbul A. Arginine physiology and its implication for wound healing. Wound Repair Regen. 2003; 11(6): 419-523.
Wu G, Bazer FW, Davis TA, Kim SW, Li P, Marc Rhoads J, Carey Satterfield M, Smith SB, Spencer TE, Yin Y. Arginine metabolism and nutrition in growth, health and disease. Amino Acids. 2009; 37(1): 153-68.
Collins CE, Kershaw J, Brockington S. Effect of nutritional supplements on wound healing in home-nursed elderly: a randomized trial. Nutrition. 2005;21(2):147-55.
Breslow RA, Hallfrisch J, Guy DG, Crawley B, Goldberg AP. The importance of dietary protein in healing pressure ulcers. J Am Geriatr Soc. 1993; 41(4) :357-62.
Barbul A, Lazarou SA, Efron DT, Wasserkrug HL, Efron G. Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery. 1990; 108(2): 331-6; discussion 336-7.
Kirk SJ, Hurson M, Regan MC, Holt DR, Wasserkrug HL, Barbul A. Arginine stimulates wound healing and immune function in elderly human beings. Surgery. 1993; 114(2): 155-9.
Hurson M, Regan MC, Kirk SJ, Wasserkrug HL, Barbul A. Metabolic effects of arginine in a healthy elderly population. JPEN J Parenter Enteral Nutr. 1995; 19(3): 227-230.
Farreras N, Artigas V, Cardona D, Rius X, Trias M, González JA. Effect of early postoperative enteral immunonutrition on wound healing in patients undergoing surgery for gastric cancer. Clinical Nutrition. 2005; 24(1): 55-65.
Chapman BR, Mills KJ, Pearce LM, Crowe TC. Use of an arginine‐enriched oral nutrition supplement in the healing of pressure ulcers in patients with spinal cord injuries: An observational study. Nutrition & Dietetics. 2011; 68: 208 - 213
Maxwell AJ, Anderson BE, Cooke JP. Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar. Vascular Medicine. 2000; 5(1): 11-19.
Piatti PM, Monti LD, Valsecchi G, Magni F, Setola E, Marchesi F, Galli-Kienle M, Pozza G, Alberti KG. Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care. 2001; 24(5): 875-880.
Desneves KJ, Todorovic BE, Cassar A, Crowe TC. Treatment with supplementary arginine, vitamin C and zinc in patients with pressure ulcers: a randomised controlled trial. Clinical Nutrition. 2005; 24(6): 979-987.
Bode-Böger SM. Einfluss von L-Arginin auf die Arterioskleroseentwicklung: Was ist therapeutisch gesichert? [Influence of L-arginine on development of atherosclerosis: what is the therapeutically assured?]. Dtsch Med Wochenschr. 2005; 130(11): 593-598.
STUDIENHEFT ZU WOBECARE® CBD AKTIV CREME:
VORTEILE VON TOPIKA:
Massey T, Derry S, Moore RA, McQuay HJ. Topical NSAIDs for acute pain in adults. Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007402. doi: 10.1002/14651858.CD007402.pub2. Update in: Cochrane Database Syst Rev. 2015;6:CD007402. PMID: 20556778; PMCID: PMC4163964.
Sheer R, Schwab P, Essex MN, Cappelleri JC, Reiners A, Bobula J, Pasquale MK. Factors Related to the Use of Topical vs. Oral NSAIDs for Sprains, Strains, and Contusions in a Senior Population: A Retrospective Analysis of Administrative Claims Data. Drugs Aging. 2018 Oct;35(10):937-950. doi: 10.1007/s40266-018-0585-8. PMID: 30203313.
STUDIEN ZUR TOPISCHEN ANWENDUNGEN VON CBD:
Lodzki M, Godin B, Rakou L, Mechoulam R, Gallily R, Touitou E. Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. J Control Release. 2003 Dec 12;93(3):377-87. doi: 10.1016/j.jconrel.2003.09.001. PMID: 14644587.
Paudel KS, Hammell DC, Agu RU, Valiveti S, Stinchcomb AL. Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers. Drug Dev Ind Pharm. 2010 Sep;36(9):1088-97. doi: 10.3109/03639041003657295. PMID: 20545522.
Bartner LR, McGrath S, Rao S, Hyatt LK, Wittenburg LA. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs. Can J Vet Res. 2018 Jul;82(3):178-183. PMID: 30026641; PMCID: PMC6038832.
Hammell DC, Zhang LP, Ma F, Abshire SM, McIlwrath SL, Stinchcomb AL, Westlund KN. Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. Eur J Pain. 2016 Jul;20(6):936-48. doi: 10.1002/ejp.818. Epub 2015 Oct 30. PMID: 26517407; PMCID: PMC4851925.
Giacoppo S, Galuppo M, Pollastro F, Grassi G, Bramanti P, Mazzon E. A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis. Daru. 2015 Oct 21;23:48. doi: 10.1186/s40199-015-0131-8. PMID: 26489494; PMCID: PMC4618347.
KLINISCHE STUDIEN ZUR TOPISCHEN ANWENDUNG VON CBD:
Nitecka-Buchta A, Nowak-Wachol A, Wachol K, Walczyńska-Dragon K, Olczyk P, Batoryna O, Kempa W, Baron S. Myorelaxant Effect of Transdermal Cannabidiol Application in Patients with TMD: A Randomized, Double-Blind Trial. J Clin Med. 2019 Nov 6;8(11):1886. doi: 10.3390/jcm8111886. PMID: 31698733; PMCID: PMC6912397.
Xu DH, Cullen BD, Tang M, Fang Y. The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities. Curr Pharm Biotechnol. 2020;21(5):390-402. doi: 10.2174/1389201020666191202111534. PMID: 31793418.
Freeman TP, Hindocha C, Green SF, Bloomfield MAP. Medicinal use of cannabis based products and cannabinoids. BMJ. 2019 Apr 4;365:l1141. doi: 10.1136/bmj.l1141. PMID: 30948383; PMCID: PMC6447998.
PFLANZENINHALTSTOFFE IM TOPISCHEN BEREICH:
BEINWELL:
Staiger C. Comfrey: a clinical overview. Phytother Res. 2012 Oct;26(10):1441-8. doi: 10.1002/ptr.4612. Epub 2012 Feb 23. PMID: 22359388; PMCID: PMC3491633.
Seigner J, Junker-Samek M, Plaza A, D'Urso G, Masullo M, Piacente S, Holper-Schichl YM, de Martin R. A Symphytum officinale Root Extract Exerts Anti-inflammatory Properties by Affecting Two Distinct Steps of NF-κB Signaling. Front Pharmacol. 2019 Apr 26;10:289. doi: 10.3389/fphar.2019.00289. PMID: 31105555; PMCID: PMC6498879.
CHMP: Community Herbal Monograph on Symphytum officinale L., radix. EMA/HMPC/572846/2009, 5 May 2015.
Deutsche Gesellschaft für Orthopädie und Orthopädische Chirurgie (DGOOC): Gonarthrose. S2k-Leitlinie, AWMF Registernummer: 033-004, 2018.
ARNIKA:
Ekenäs C, Zebrowska A, Schuler B, Vrede T, Andreasen K, Backlund A, Merfort I, Bohlin L. Screening for anti-inflammatory activity of 12 Arnica (Asteraceae) species assessed by inhibition of NF-kappaB and release of human neutrophil elastase. Planta Med. 2008 Dec;74(15):1789-94. doi: 10.1055/s-0028-1088320. Epub 2008 Oct 30. PMID: 18975264.
Seigner J, Junker-Samek M, Plaza A, D'Urso G, Masullo M, Piacente S, Holper-Schichl YM, de Martin R. A Symphytum officinale Root Extract Exerts Anti-inflammatory Properties by Affecting Two Distinct Steps of NF-κB Signaling. Front Pharmacol. 2019 Apr 26;10:289. doi: 10.3389/fphar.2019.00289. PMID: 31105555; PMCID: PMC6498879.
(Wirkmechanismus wie bei Beinwell)
CHMP: Community Herbal Monograph on Arnica montana L., flos. EMA/HMPC/198793/2012.
Cameron M, Chrubasik S. Topical herbal therapies for treating osteoarthritis. Cochrane Database Syst Rev. 2013 May 31;5(5):CD010538. doi: 10.1002/14651858.CD010538. PMID: 23728701; PMCID: PMC4105203.
MENTHOL:
Pergolizzi JV Jr, Taylor R Jr, LeQuang JA, Raffa RB; NEMA Research Group. The role and mechanism of action of menthol in topical analgesic products. J Clin Pharm Ther. 2018 Jun;43(3):313-319. doi: 10.1111/jcpt.12679. Epub 2018 Mar 10. PMID: 29524352.
Karashima Y, Damann N, Prenen J, Talavera K, Segal A, Voets T, Nilius B. Bimodal action of menthol on the transient receptor potential channel TRPA1. J Neurosci. 2007 Sep 12;27(37):9874-84. doi: 10.1523/JNEUROSCI.2221-07.2007. PMID: 17855602; PMCID: PMC6672629.
Juergens UR, Stöber M, Vetter H. The anti-inflammatory activity of L-menthol compared to mint oil in human monocytes in vitro: a novel perspective for its therapeutic use in inflammatory diseases. Eur J Med Res. 1998 Dec 16;3(12):539-45. PMID: 9889172.
CHMP: Community Herbal Monograph on Mentha X Piperita L., Aetheroleum. EMEA/HMPC/349466/2006.
KAMPFER:
Xu H, Blair NT, Clapham DE. Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. J Neurosci. 2005 Sep 28;25(39):8924-37. doi: 10.1523/JNEUROSCI.2574-05.2005. PMID: 16192383; PMCID: PMC6725586.
Chen J, Jiang QD, Chai YP, Zhang H, Peng P, Yang XX. Natural Terpenes as Penetration Enhancers for Transdermal Drug Delivery. Molecules. 2016 Dec 11;21(12):1709. doi: 10.3390/molecules21121709. PMID: 27973428; PMCID: PMC6273457.
ALOE VERA:
Boudreau MD, Beland FA. An evaluation of the biological and toxicological properties of Aloe barbadensis (miller), Aloe vera. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2006 Apr;24(1):103-54. doi: 10.1080/10590500600614303. PMID: 16690538.
Dal'Belo SE, Gaspar LR, Maia Campos PM. Moisturizing effect of cosmetic formulations containing Aloe vera extract in different concentrations assessed by skin bioengineering techniques. Skin Res Technol. 2006 Nov;12(4):241-6. doi: 10.1111/j.0909-752X.2006.00155.x. PMID: 17026654.
Vogler BK, Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract. 1999 Oct;49(447):823-8. PMID: 10885091; PMCID: PMC1313538.
WINTERGRÜN:
Michel P, Owczarek A, Matczak M, Kosno M, Szymański P, Mikiciuk-Olasik E, Kilanowicz A, Wesołowski W, Olszewska MA. Metabolite Profiling of Eastern Teaberry (Gaultheria procumbens L.) Lipophilic Leaf Extracts with Hyaluronidase and Lipoxygenase Inhibitory Activity. Molecules. 2017 Mar 6;22(3):412. doi: 10.3390/molecules22030412. PMID: 28272321; PMCID: PMC6155426.
Mao P, Liu Z, Xie M, Jiang R, Liu W, Wang X, Meng S, She G. Naturally occurring methyl salicylate glycosides. Mini Rev Med Chem. 2014 Jan;14(1):56-63. doi: 10.2174/1389557513666131211110004. PMID: 24329991.
ZYTOKINREGULIERUNG DURCH ENZYME:
Birkenmeier G. Wirkungsmechanismen von oral applizierten proteolytischen Enzymen – Mechanistische und therapeutische Aspekte. Dtsch Med Wschr 2008; 133, 5301 – 5302.
LaMarre J, Wollenberg GK, Gonias SL, Hayes MA. Cytokine binding and clearance properties of proteinase-activated alpha 2-macroglobulins. Lab Invest. 1991 Jul;65(1):3-14. PMID: 1712874.
Lauer D, Müller R, Cott C, Otto A, Naumann M, Birkenmeier G. Modulation of growth factor binding properties of alpha2-macroglobulin by enzyme therapy. Cancer Chemother Pharmacol. 2001 Jul;47 Suppl:S4-9. doi: 10.1007/s002800170002. PMID: 11561872.
BEI ARTHROSE:
Bolten WW, Glade MJ, Raum S, Ritz BW. The safety and efficacy of an enzyme combination in managing knee osteoarthritis pain in adults: a randomized, double-blind, placebo-controlled trial. Arthritis. 2015;2015:251521. doi: 10.1155/2015/251521. Epub 2015 Jan 31. PMID: 25802756; PMCID: PMC4329848.
Klein G, Kullich W, Schnitker J, Schwann H. Efficacy and tolerance of an oral enzyme combination in painful osteoarthritis of the hip. A double-blind, randomised study comparing oral enzymes with non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol. 2006 Jan-Feb;24(1):25-30. PMID: 16539815.
Akhtar NM, Naseer R, Farooqi AZ, Aziz W, Nazir M. Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee--a double-blind prospective randomized study. Clin Rheumatol. 2004 Oct;23(5):410-5. doi: 10.1007/s10067-004-0902-y. Epub 2004 Jul 24. PMID: 15278753.
Singer F, Singer C, Oberleitner H. Phlogenzym® versus diclofenac in the treatment of activated osteoarthritis of the knee. A double-blind prospective randomized study, International Journal of Immunotherapy 2001; 17(2):135-141.
Klein G, Kullich W. Short-Term Treatment of Painful Osteoarthritis of the Knee with Oral Enzymes: A Randomised, Double-Blind Study versus Diclofenac, Clinical Drug Investigation 2000;19: 15-23.
IN DER TRAUMATOLOGIE:
Marzin T, Lorkowski G, Reule C, Rau S, Pabst E, Vester JC, Pabst H. Effects of a systemic enzyme therapy in healthy active adults after exhaustive eccentric exercise: a randomised, two-stage, double-blinded, placebo-controlled trial. BMJ Open Sport Exerc Med. 2017 Mar 12;2(1):e000191. doi: 10.1136/bmjsem-2016-000191. PMID: 28879033; PMCID: PMC5569274.
Rahn, H.-D. "Distorsion Des Oberen Sprunggelenks. Verkürzte Heilzeiten Bei Systemischer Therapie Mit Hydrolytischen Enzymen - Ein Vergleich Zweier Enzymkombinationspräparate Mit Plazebo." Deutsche Zeitschrift Für Sportmedizin 46.9 (1995): S. 426-431.
ENZYME/BROMELAIN:
Fitzhugh DJ, Shan S, Dewhirst MW, Hale LP. Bromelain treatment decreases neutrophil migration to sites of inflammation. Clin Immunol. 2008 Jul;128(1):66-74. doi: 10.1016/j.clim.2008.02.015. Epub 2008 May 14. PMID: 18482869; PMCID: PMC2516972.
Engwerda CR, Andrew D, Murphy M, Mynott TL. Bromelain activates murine macrophages and natural killer cells in vitro. Cell Immunol. 2001 May 25;210(1):5-10. doi: 10.1006/cimm.2001.1793. PMID: 11485347.
Wu SM, Patel DD, Pizzo SV. Oxidized alpha2-macroglobulin (alpha2M) differentially regulates receptor binding by cytokines/growth factors: implications for tissue injury and repair mechanisms in inflammation. J Immunol. 1998 Oct 15;161(8):4356-65. PMID: 9780213.
Hale LP, Haynes BF. Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. J Immunol. 1992 Dec 15;149(12):3809-16. PMID: 1281188.
Desser L, Rehberger A, Kokron E, Paukovits W. Cytokine synthesis in human peripheral blood mononuclear cells after oral administration of polyenzyme preparations. Oncology. 1993 Nov-Dec;50(6):403-7. doi: 10.1159/000227219. PMID: 7694216.
Gebauer F, Stauder G, Kunze R. Proteolytic Enzymes Modulate Preformed, Fixed Immunocomplexes and the Process of Immunocomplex-Formation In Vitro. Journal of Nutritional Immunology. 1995; 3(3):19–39.
VITAMIN C:
Carr AC, Maggini S. Vitamin C and Immune Function. Nutrients. 2017 Nov 3;9(11):1211. doi: 10.3390/nu9111211. PMID: 29099763; PMCID: PMC5707683.
Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD000980. doi: 10.1002/14651858.CD000980.pub4. PMID: 23440782.
VITAMIN D:
Colotta F, Jansson B, Bonelli F. Modulation of inflammatory and immune responses by vitamin D. J Autoimmun. 2017 Dec;85:78-97. doi: 10.1016/j.jaut.2017.07.007. Epub 2017 Jul 18. PMID: 28733125.
Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015 May 29;7(6):4240-70. doi: 10.3390/nu7064240. PMID: 26035247; PMCID: PMC4488782.
Sassi F, Tamone C, D'Amelio P. Vitamin D: Nutrient, Hormone, and Immunomodulator. Nutrients. 2018 Nov 3;10(11):1656. doi: 10.3390/nu10111656. PMID: 30400332; PMCID: PMC6266123.
VITAMIN E:
Hemilä H. Vitamin E administration may decrease the incidence of pneumonia in elderly males. Clin Interv Aging. 2016 Oct 3;11:1379-1385. doi: 10.2147/CIA.S114515. PMID: 27757026; PMCID: PMC5055121.
Lee GY, Han SN. The Role of Vitamin E in Immunity. Nutrients. 2018 Nov 1;10(11):1614. doi: 10.3390/nu10111614. PMID: 30388871; PMCID: PMC6266234.
Ziegler M, Wallert M, Lorkowski S, Peter K. Cardiovascular and Metabolic Protection by Vitamin E: A Matter of Treatment Strategy? Antioxidants (Basel). 2020 Sep 29;9(10):935. doi: 10.3390/antiox9100935. PMID: 33003543; PMCID: PMC7600583.
ZINK:
Bonaventura P, Benedetti G, Albarède F, Miossec P. Zinc and its role in immunity and inflammation. Autoimmun Rev. 2015 Apr;14(4):277-85. doi: 10.1016/j.autrev.2014.11.008. Epub 2014 Nov 24. PMID: 25462582.
Gammoh NZ, Rink L. Zinc in Infection and Inflammation. Nutrients. 2017 Jun 17;9(6):624. doi: 10.3390/nu9060624. PMID: 28629136; PMCID: PMC5490603.
Ohashi W, Fukada T. Contribution of Zinc and Zinc Transporters in the Pathogenesis of Inflammatory Bowel Diseases. J Immunol Res. 2019 Mar 10;2019:8396878. doi: 10.1155/2019/8396878. PMID: 30984791; PMCID: PMC6431494.
SELEN:
Avery JC, Hoffmann PR. Selenium, Selenoproteins, and Immunity. Nutrients. 2018 Sep 1;10(9):1203. doi: 10.3390/nu10091203. PMID: 30200430; PMCID: PMC6163284.
Guillin OM, Vindry C, Ohlmann T, Chavatte L. Selenium, Selenoproteins and Viral Infection. Nutrients. 2019 Sep 4;11(9):2101. doi: 10.3390/nu11092101. PMID: 31487871; PMCID: PMC6769590. https://pubmed.ncbi.nlm.nih.gov/31487871/
POLYPHENOLE/FLAVONOIDEN:
Rauf A, Imran M, Abu-Izneid T, Iahtisham-Ul-Haq, Patel S, Pan X, Naz S, Sanches Silva A, Saeed F, Rasul Suleria HA. Proanthocyanidins: A comprehensive review. Biomed Pharmacother. 2019 Aug;116:108999. doi: 10.1016/j.biopha.2019.108999. Epub 2019 May 27. PMID: 31146109.
Shi J, Yu J, Pohorly JE, Kakuda Y. Polyphenolics in grape seeds-biochemistry and functionality. J Med Food. 2003 Winter;6(4):291-9. doi: 10.1089/109662003772519831. PMID: 14977436.
QUERCETIN:
Colunga Biancatelli RML, Berrill M, Catravas JD, Marik PE. Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19). Front Immunol. 2020 Jun 19;11:1451. doi: 10.3389/fimmu.2020.01451. PMID: 32636851; PMCID: PMC7318306.
Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, Liu H, Yin Y. Quercetin, Inflammation and Immunity. Nutrients. 2016 Mar 15;8(3):167. doi: 10.3390/nu8030167. PMID: 26999194; PMCID: PMC4808895.
McAnlis GT, McEneny J, Pearce J, Young IS. Absorption and antioxidant effects of quercetin from onions, in man. Eur J Clin Nutr. 1999 Feb;53(2):92-6. doi: 10.1038/sj.ejcn.1600682. PMID: 10099940.
BETA-GLUCANE:
Talbott S, Talbott J. Effect of BETA 1, 3/1, 6 GLUCAN on Upper Respiratory Tract Infection Symptoms and Mood State in Marathon Athletes. J Sports Sci Med. 2009 Dec 1;8(4):509-15. PMID: 24149590; PMCID: PMC3761532.
Fuller R, Moore MV, Lewith G, Stuart BL, Ormiston RV, Fisk HL, Noakes PS, Calder PC. Yeast-derived β-1,3/1,6 glucan, upper respiratory tract infection and innate immunity in older adults. Nutrition. 2017 Jul-Aug;39-40:30-35. doi: 10.1016/j.nut.2017.03.003. Epub 2017 Mar 23. PMID: 28606567.
Dharsono T, Rudnicka K, Wilhelm M, Schoen C. Effects of Yeast (1,3)-(1,6)-Beta-Glucan on Severity of Upper Respiratory Tract Infections: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Subjects. J Am Coll Nutr. 2019 Jan;38(1):40-50. doi: 10.1080/07315724.2018.1478339. Epub 2018 Sep 10. PMID: 30198828.
De Marco Castro E, Calder PC, Roche HM. β-1,3/1,6-Glucans and Immunity: State of the Art and Future Directions. Mol Nutr Food Res. 2021 Jan;65(1):e1901071. doi: 10.1002/mnfr.201901071. Epub 2020 Apr 27. PMID: 32223047; PMCID: PMC7816268.
Bashir KMI, Choi JS. Clinical and Physiological Perspectives of β-Glucans: The Past, Present, and Future. Int J Mol Sci. 2017 Sep 5;18(9):1906. doi: 10.3390/ijms18091906. PMID: 28872611; PMCID: PMC5618555.
STUDIEN ZUR REGENERATION IM SPORT:
Wobenzym® sport Studienheft
BROMELAIN:
Berg A, Peters M, Deibert P, König D, Birnesser H. Bromelain – Übersicht und Diskussion zur therapeutischen Anwendung und seiner Bedeutung in der Sportmedizin und Sporttraumatologie. Deutsche Zeitschrift für Sportmedizin Jahrgang 56, Nr. 1 (2005).
Mueller K, Hingst J. The Athlete’s Guide to Sports Supplements. January 2013. DOI:10.5040/9781492595991, ISBN: 9780736093699
In ResearchGate öffnen oder als PDF herunterladen
BROMELAIN – PRÄKLINISCHE STUDIE:
Walker JA, Cerny FJ, Cotter JR, Burton HW. Attenuation of contraction-induced skeletal muscle injury by bromelain. Med Sci Sports Exerc. 1992 Jan;24(1):20-5. PMID: 1548991.
BROMELAIN – KLINISCHE STUDIEN:
Buford TW, Cooke MB, Redd LL, Hudson GM, Shelmadine BD, Willoughby DS. Protease supplementation improves muscle function after eccentric exercise. Med Sci Sports Exerc. 2009 Oct;41(10):1908-14. doi: 10.1249/MSS.0b013e3181a518f0. PMID: 19727022.
Marzin T, Lorkowski G, Reule C, Rau S, Pabst E, Vester JC, Pabst H. Effects of a systemic enzyme therapy in healthy active adults after exhaustive eccentric exercise: a randomised, two-stage, double-blinded, placebo-controlled trial. BMJ Open Sport Exerc Med. 2017 Mar 12;2(1):e000191. doi: 10.1136/bmjsem-2016-000191. PMID: 28879033; PMCID: PMC5569274.
KURKUMA UND BOSWELLIA:
McFarlin BK, Venable AS, Henning AL, Sampson JN, Pennel K, Vingren JL, Hill DW. Reduced inflammatory and muscle damage biomarkers following oral supplementation with bioavailable curcumin. BBA Clin. 2016 Feb 18;5:72-8. doi: 10.1016/j.bbacli.2016.02.003. PMID: 27051592; PMCID: PMC4802396.
Chilelli NC, Ragazzi E, Valentini R, Cosma C, Ferraresso S, Lapolla A, Sartore G. Curcumin and Boswellia serrata Modulate the Glyco-Oxidative Status and Lipo-Oxidation in Master Athletes. Nutrients. 2016 Nov 21;8(11):745. doi: 10.3390/nu8110745. PMID: 27879642; PMCID: PMC5133128.
Drobnic F, Riera J, Appendino G, Togni S, Franceschi F, Valle X, Pons A, Tur J. Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial. J Int Soc Sports Nutr. 2014 Jun 18;11:31. doi: 10.1186/1550-2783-11-31. PMID: 24982601; PMCID: PMC4074833.
SAUERKIRSCHE:
Clifford, M. Anthocyanins – nature, occurrence and dietary burden. Journal of the Science of Food and Agriculture 80 (2000): 1063-1072.
In ResearchGate öffnen oder in Online Library Wiley öffnen
Bell PG, McHugh MP, Stevenson E, Howatson G. The role of cherries in exercise and health. Scand J Med Sci Sports. 2014 Jun;24(3):477-90. doi: 10.1111/sms.12085. Epub 2013 May 27. PMID: 23710994.
SAUERKIRSCHE – KLINISCHE STUDIEN:
Bowtell JL, Sumners DP, Dyer A, Fox P, Mileva KN. Montmorency cherry juice reduces muscle damage caused by intensive strength exercise. Med Sci Sports Exerc. 2011 Aug;43(8):1544-51. doi: 10.1249/MSS.0b013e31820e5adc. PMID: 21233776.
Connolly DA, McHugh MP, Padilla-Zakour OI, Carlson L, Sayers SP. Efficacy of a tart cherry juice blend in preventing the symptoms of muscle damage. Br J Sports Med. 2006 Aug;40(8):679-83; discussion 683. doi: 10.1136/bjsm.2005.025429. Epub 2006 Jun 21. PMID: 16790484; PMCID: PMC2579450.
Bell PG, Stevenson E, Davison GW, Howatson G. The Effects of Montmorency Tart Cherry Concentrate Supplementation on Recovery Following Prolonged, Intermittent Exercise. Nutrients. 2016 Jul 22;8(7):441. doi: 10.3390/nu8070441. PMID: 27455316; PMCID: PMC4963917.
Levers K, Dalton R, Galvan E, Goodenough C, O'Connor A, Simbo S, Barringer N, Mertens-Talcott SU, Rasmussen C, Greenwood M, Riechman S, Crouse S, Kreider RB. Effects of powdered Montmorency tart cherry supplementation on an acute bout of intense lower body strength exercise in resistance trained males. J Int Soc Sports Nutr. 2015 Nov 16;12:41. doi: 10.1186/s12970-015-0102-y. PMID: 26578852; PMCID: PMC4647629.
Levers K, Dalton R, Galvan E, O'Connor A, Goodenough C, Simbo S, Mertens-Talcott SU, Rasmussen C, Greenwood M, Riechman S, Crouse S, Kreider RB. Effects of powdered Montmorency tart cherry supplementation on acute endurance exercise performance in aerobically trained individuals. J Int Soc Sports Nutr. 2016 May 26;13:22. doi: 10.1186/s12970-016-0133-z. PMID: 27231439; PMCID: PMC4880859.
AKTUELLE EMPFEHLUNGEN ZUR REGENERATION - BROMELAIN/CURCUMIN/SAUERKIRSCHE:
Internationale Olympische Komitee (IOC) Statement: Curcumin und Sauerkirsche:
Maughan RJ, Burke LM, Dvorak J, Larson-Meyer DE, Peeling P, Phillips SM, Rawson ES, Walsh NP, Garthe I, Geyer H, Meeusen R, van Loon LJC, Shirreffs SM, Spriet LL, Stuart M, Vernec A, Currell K, Ali VM, Budgett RG, Ljungqvist A, Mountjoy M, Pitsiladis YP, Soligard T, Erdener U, Engebretsen L. IOC consensus statement: dietary supplements and the high-performance athlete. Br J Sports Med. 2018 Apr;52(7):439-455. doi: 10.1136/bjsports-2018-099027. Epub 2018 Mar 14. PMID: 29540367; PMCID: PMC5867441.
Bromelain und Curcumin:
Heaton LE, Davis JK, Rawson ES, Nuccio RP, Witard OC, Stein KW, Baar K, Carter JM, Baker LB. Selected In-Season Nutritional Strategies to Enhance Recovery for Team Sport Athletes: A Practical Overview. Sports Med. 2017 Nov;47(11):2201-2218. doi: 10.1007/s40279-017-0759-2. PMID: 28702900; PMCID: PMC5633631.
Curcumin und Sauerkirsche:
Rawson ES, Miles MP, Larson-Meyer DE. Dietary Supplements for Health, Adaptation, and Recovery in Athletes. Int J Sport Nutr Exerc Metab. 2018 Mar 1;28(2):188-199. doi: 10.1123/ijsnem.2017-0340. Epub 2018 Feb 19. PMID: 29345167.
Sauerkirsche:
Ranchordas MK, Dawson JT, Russell M. Practical nutritional recovery strategies for elite soccer players when limited time separates repeated matches. J Int Soc Sports Nutr. 2017 Sep 12;14:35. doi: 10.1186/s12970-017-0193-8. PMID: 28919844; PMCID: PMC5596842.
